Use este identificador para citar ou linkar para este item: http://repositorio.ufc.br/handle/riufc/10224
Tipo: Artigo de Periódico
Título: Synthesis and cytotoxic evaluation of a series of 2-amino-naphthoquinones against human cancer cells
Autor(es): Moraes, Thiago A. P. de
S. Filha, Maria J.
Camara, Celso A.
Silva, Tania M. S.
Soares, Bruno M.
Bomfim, Igor S.
Pessoa, Claudia
Ximenes, George C.
Silva Junior, Valdemiro A.
Palavras-chave: Naftoquinonas;Glioblastoma
Data do documento: 2014
Instituição/Editor/Publicador: Molecules
Citação: MORAES, T. A. P. de et al. Synthesis and cytotoxic evaluation of a series of 2-Amino-Naphthoquinones against Human cancer cells. Molecules, Basel, v. 19, p. 13188-99, 2014.
Abstract: The cytotoxicity of a series of aminonaphthoquinones resulting from the reaction of suitable aminoacids with 1,4-naphthoquinone was assayed against SF-295 (glioblastoma), MDAMB-435 (breast), HCT-8 (colon), HCT-116 (colon), HL-60 (leukemia), OVCAR-8 (ovarian), NCI-H358M (bronchoalveolar lung carcinoma) and PC3-M (prostate) cancer cells and also against PBMC (peripheral blood mononuclear cells). The results demonstrated that all the synthetic aminonaphthoquinones had relevant cytotoxic activity against all human cancer lines used in this experiment. Five of the compounds showed high cytotoxicity and selectivity against all cancer cell lines tested (IC50 = 0.49 to 3.89 μg·mL−1). The title compounds were less toxic to PBMC, since IC50 was 1.5 to eighteen times higher (IC50 = 5.51 to 17.61 μg·mL−1) than values shown by tumour cell lines. The mechanism of cell growth inhibition and structure–activity relationships remains as a target for future investigations.
URI: http://www.repositorio.ufc.br/handle/riufc/10224
ISSN: 1420-3049
Aparece nas coleções:DFIFA - Artigos publicados em revista científica

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2014_art_bmsoares.pdf760,08 kBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.